1,6-Diaza-spiro[3.3]heptane-6-carboxylic acid tert-butyl ester hydrochloride, 95%, 500mg

4-chlorobenzene-1-sulfonamide, 95.0%, 500g

Long working distance plan phase Fluarex contrast 20x/0.45 infinity corrected IOS objective, corrected for 1 mm petri dish thickness

1-Chloroethyl ethyl carbonate, 95.0%, 100g

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-1-one, 95.0%, 1g

3-Phenylisoxazole, 95.0%, 1g

N'-[1-Amino-1-p-toylmethylidene]hydrazinecarboxylic acid tert-butyl ester, 95.0%, 1g

2-Methyl-4-(trifluoromethoxy)benzoic acid, 95.0%, 100mg

5-(Aminomethyl)-3-(4-fluorophenyl)-1,3-oxazolidin-2-one hydrochloride, 95.0%, 250mg

2,3-Diphenylcycloprop-2-en-1-one>90.0%(HPLC)(qNMR)5g

Ethyl 3-chlorobenzoate, 98.0%, 25g

Ethyl 1-(2-chloroacetyl)piperidine-4-carboxylate, 95.0%, 5g

4- Bromo-3,5-dichlorothiophenol, 5g